Unknown

Dataset Information

0

Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine-Selective Protein Modification and Charge Modulation.


ABSTRACT: Quaternized vinyl- and alkynyl-pyridine reagents were shown to react in an ultrafast and selective manner with several cysteine-tagged proteins at near-stoichiometric quantities. We have demonstrated that this method can effectively create a homogenous antibody-drug conjugate that features a precise drug-to-antibody ratio of 2, which was stable in human plasma and retained its specificity towards Her2+ cells. Finally, the developed warhead introduces a +1 charge to the overall net charge of the protein, which enabled us to show that the electrophoretic mobility of the protein may be tuned through the simple attachment of a quaternized vinyl pyridinium reagent at the cysteine residues. We anticipate the generalized use of quaternized vinyl- and alkynyl-pyridine reagents not only for bioconjugation, but also as warheads for covalent inhibition and as tools to profile cysteine reactivity.

SUBMITTER: Matos MJ 

PROVIDER: S-EPMC6618083 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine-Selective Protein Modification and Charge Modulation.

Matos Maria J MJ   Navo Claudio D CD   Hakala Tuuli T   Ferhati Xhenti X   Guerreiro Ana A   Hartmann David D   Bernardim Barbara B   Saar Kadi L KL   Compañón Ismael I   Corzana Francisco F   Knowles Tuomas P J TPJ   Jiménez-Osés Gonzalo G   Bernardes Gonçalo J L GJL  

Angewandte Chemie (International ed. in English) 20190409 20


Quaternized vinyl- and alkynyl-pyridine reagents were shown to react in an ultrafast and selective manner with several cysteine-tagged proteins at near-stoichiometric quantities. We have demonstrated that this method can effectively create a homogenous antibody-drug conjugate that features a precise drug-to-antibody ratio of 2, which was stable in human plasma and retained its specificity towards Her2+ cells. Finally, the developed warhead introduces a +1 charge to the overall net charge of the  ...[more]

Similar Datasets

| S-EPMC6680477 | biostudies-literature
| S-EPMC10476183 | biostudies-literature
| S-EPMC8453815 | biostudies-literature
| S-EPMC8621047 | biostudies-literature
| S-EPMC4518297 | biostudies-literature
| S-EPMC3826635 | biostudies-literature
| S-EPMC6430016 | biostudies-literature
| S-EPMC4848519 | biostudies-literature
| S-EPMC3344187 | biostudies-literature
| S-EPMC9165659 | biostudies-literature